Neogen (NEOG) to Release Quarterly Earnings on Wednesday

Neogen (NASDAQ:NEOG) is expected to be releasing its Q3 2026 results before the market opens on Wednesday, April 8th. Analysts expect Neogen to post earnings of $0.04 per share and revenue of $204.6150 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earning report page for the latest details on the call scheduled for Wednesday, April 8, 2026 at 8:00 AM ET.

Neogen (NASDAQ:NEOG) last posted its earnings results on Thursday, January 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.03. Neogen had a negative net margin of 68.47% and a positive return on equity of 2.14%. The firm had revenue of $224.69 million during the quarter, compared to analyst estimates of $208.50 million. During the same period in the previous year, the business posted $0.11 EPS. Neogen’s revenue was down 2.9% on a year-over-year basis. On average, analysts expect Neogen to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Neogen Price Performance

NASDAQ NEOG opened at $9.29 on Wednesday. The company has a 50-day moving average price of $10.14 and a two-hundred day moving average price of $7.81. Neogen has a 52 week low of $3.87 and a 52 week high of $11.43. The stock has a market cap of $2.02 billion, a price-to-earnings ratio of -3.35 and a beta of 1.95. The company has a current ratio of 3.91, a quick ratio of 2.80 and a debt-to-equity ratio of 0.38.

Institutional Trading of Neogen

Several institutional investors have recently modified their holdings of the company. AQR Capital Management LLC grew its holdings in Neogen by 217.0% during the first quarter. AQR Capital Management LLC now owns 52,410 shares of the company’s stock worth $443,000 after acquiring an additional 35,878 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Neogen by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company’s stock valued at $1,125,000 after acquiring an additional 5,638 shares during the last quarter. Jones Financial Companies Lllp lifted its holdings in Neogen by 5,687.3% in the 1st quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company’s stock valued at $290,000 after acquiring an additional 32,816 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Neogen by 14.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company’s stock valued at $14,553,000 after purchasing an additional 209,990 shares in the last quarter. Finally, United Services Automobile Association bought a new position in shares of Neogen during the 1st quarter valued at about $112,000. Institutional investors and hedge funds own 96.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on NEOG shares. Wall Street Zen raised Neogen from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Neogen in a research report on Monday, December 29th. Piper Sandler reissued a “neutral” rating and issued a $10.00 price target (up from $6.50) on shares of Neogen in a research note on Monday, January 12th. William Blair reissued a “market perform” rating on shares of Neogen in a report on Monday, March 2nd. Finally, Guggenheim restated a “buy” rating and set a $12.00 price objective (up from $8.00) on shares of Neogen in a research note on Friday, January 9th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $10.67.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.